XML 105 R78.htm IDEA: XBRL DOCUMENT v3.5.0.2
Fair Value Measurements - Additional Information (Detail)
€ in Millions, $ in Millions
12 Months Ended
Jun. 10, 2015
USD ($)
Feb. 26, 2015
USD ($)
Oct. 17, 2013
USD ($)
Oct. 17, 2013
EUR (€)
Jun. 30, 2016
USD ($)
Jun. 30, 2015
USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Estimate fair value of contingent consideration liability           $ 6.8
Payment towards contingent consideration liability         $ 3.5  
Selling, General and Administrative Expense [Member]            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Estimate fair value of contingent consideration liability         3.3  
TowerSec Ltd. [Member]            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Estimate fair value of contingent consideration liability         27.7  
Red Bend Ltd. [Member]            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Estimate fair value of contingent consideration liability   $ 20.9     18.4 16.7
Contingent consideration liability         30.0  
Red Bend Ltd. [Member] | Selling, General and Administrative Expense [Member]            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Estimate fair value of contingent consideration liability         1.1  
Red Bend Ltd. [Member] | Goodwill [Member]            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Estimate fair value of contingent consideration liability         2.8  
Southern Vision Systems Inc [Member]            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Estimate fair value of contingent consideration liability $ 3.0       3.0  
Contingent consideration liability         10.0  
Southern Vision Systems Inc [Member] | Previously Reported [Member]            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Estimate fair value of contingent consideration liability           0.0
Duran Audio BV [Member]            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Estimate fair value of contingent consideration liability     $ 0.9 € 0.7 1.6  
Payment towards contingent consideration liability         0.3 0.3
Duran Audio BV [Member] | Previously Reported [Member]            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Estimate fair value of contingent consideration liability           2.2
Duran Audio BV [Member] | Selling, General and Administrative Expense [Member]            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Estimate fair value of contingent consideration liability         0.3  
IPSG/VFX [Member]            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Estimate fair value of contingent consideration liability         0.0  
IPSG/VFX [Member] | Previously Reported [Member]            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Estimate fair value of contingent consideration liability           $ 5.8
Symphony Teleca Corporation [Member]            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Payment towards contingent consideration liability         23.3  
Interest accretion recorded to increase liability         1.1  
Symphony Teleca Corporation [Member] | Selling, General and Administrative Expense [Member]            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Estimate fair value of contingent consideration liability         $ 3.1